Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ONCOZ.STthis companyOncoZenge AB (publ)	SEK 3.30	-5.16×	-139.7×	30.78×	-5.41×	-72.6%	-181.7%	-595.7%	-598.3%	2715.5%	-229.6%	-15.9%	-12.78×	-0.24×	-93.91×	1.01×	0.0%	2	-18.16	2	C
ACOU.STAcouSort AB	SEK 3.12	-4.42×	3.27×	7.79×	-3.29×	-1703.2%	-211.6%	-211.6%	-177.3%	-74.6%	-89.0%	-32.4%	0×	0.44×	-10.85×	8.19×	0.0%	2	-4.93	1	D+
ATORX.STAlligator Bioscience AB (publ)	SEK 0.01	-0.18×	1.35×	18.04×	0.08×	6004.4%	-10665.2%	-23780.5%	-9990.3%	-748.7%	-244.4%	-1697.7%	6.29×	0.16×	-2.76×	0.88×	0.0%	1	-24.71	2	B-
EXPRS2.STExpreS2ion Biotech Holding AB (publ)	SEK 0.91	-1.19×	1.27×	12.37×	0×	1336.2%	-1171.5%	-1444.4%	-1041.4%	-106.7%	-121.9%	-90.4%	0.06×	0.88×	-117.12×	2.04×	0.0%	2	-2.66	3	B
NEWBRY.STNewbury Pharmaceuticals AB (publ)	SEK 1.70	-3.35×	0×	1.79×	0×	-52637.2%	24.8%	-48.4%	-53.7%	0.0%	0.0%	0.0%	0×	0×	0×	0×	0.0%	1	0.45	1	D+
ORTI-B.STOrtivus AB (publ)	SEK 1.15	-2.9×	2.8×	0.86×	-6.94×	-251.1%	40.3%	-19.7%	-29.8%	-97.6%	-34.4%	-55.5%	0.87×	-1.01×	-7.78×	0.98×	0.0%	1	1.31	1	D+
Peer median	—	-2.9×	1.35×	7.79×	0×	-251.1%	-211.6%	-211.6%	-177.3%	-97.6%	-89.0%	-55.5%	0.06×	0.16×	-7.78×	0.98×	0.0%	1	-2.66	1	—